Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5β1 integrins and hyaluronic acid

Gynecologic Oncology

Volumn 134, Issue 3, 2014, Pages 624-630

  Mikuła Pietrasik, Justyna ^a   Sosińska, Patrycja ^a   Książek, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Adhesion; Hyaluronic acid; Integrins; Ovarian cancer; Resveratrol

Indexed keywords

FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; RESVERATROL; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN; VITRONECTIN RECEPTOR; ANTINEOPLASTIC AGENT; INTEGRIN; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIUM; OMENTUM; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; ADHESION; BIOSYNTHESIS; DRUG EFFECT; EPITHELIUM; EPITHELIUM CELL; OVARY CANCER; OVARY TUMOR; PATHOLOGY; PERITONEUM; TUMOR CELL CULTURE;

ADHESION; HYALURONIC ACID; INTEGRINS; OVARIAN CANCER; RESVERATROL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; HYALURONIC ACID; INTEGRIN ALPHA5BETA1; OVARIAN NEOPLASMS; PERITONEUM; STILBENES; TUMOR CELLS, CULTURED;

EID: 84908371031     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.06.022     Document Type: Article

References (31)

1. Amadori, D., Sansoni, E., Amadori, A., Ovarian cancer: natural history and metastatic pattern. Front Biosci 2 (1-1-1997), g8–g10.
2. Lessan, K., Aguiar, D.J., Oegema, T., Siebenson, L., Skubitz, A.P., CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154 (1999), 1525–1537.
3. Ahmed, N., Riley, C., Rice, G., Quinn, M., Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis 22 (2005), 391–402.
4. Gardner, M.J., Catterall, J.B., Jones, L.M., Turner, G.A., Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin Exp Metastasis 14 (1996), 325–334.
5. Heyman, L., Kellouche, S., Fernandes, J., Dutoit, S., Poulain, L., Carreiras, F., Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro. Tumour Biol 29 (2008), 231–244.
6. Fulda, S., Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov Today 15 (2010), 757–765.
7. Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S., Takada, Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24 (2004), 2783–2840.
8. Kang, N.H., Hwang, K.A., Lee, H.R., Choi, D.W., Choi, K.C., Resveratrol regulates the cell viability promoted by 17beta-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor alpha and insulin growth factor-1 receptor in BG-1 ovarian cancer cells. Food Chem Toxicol 59 (2013), 373–379.
9. Jeong, K.J., Cho, K.H., Panupinthu, N., Kim, H., Kang, J., Park, C.G., et al. EGFR mediates LPA-induced proteolytic enzyme expression and ovarian cancer invasion: inhibition by resveratrol. Mol Oncol 7 (2013), 121–129.
10. Lin, C., Crawford, D.R., Lin, S., Hwang, J., Sebuyira, A., Meng, R., et al. Inducible COX-2-dependent apoptosis in human ovarian cancer cells. Carcinogenesis 32 (2011), 19–26.
11. Opipari, A.W. Jr., Tan, L., Boitano, A.E., Sorenson, D.R., Aurora, A., Liu, J.R., Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64 (1-15-2004), 696–703.
12. Cao, Z., Fang, J., Xia, C., Shi, X., Jiang, B.H., trans-3,4,5′-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 10 (8-1-2004), 5253–5263.
13. Vergara, D., Simeone, P., Toraldo, D., Del, B.P., Vergaro, V., Leporatti, S., et al. Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. Mol Biosyst 8 (2012), 1078–1087.
14. Nessa, M.U., Beale, P., Chan, C., Yu, J.Q., Huq, F., Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells. Anticancer Res 32 (2012), 53–59.
15. Murias, M., Miksits, M., Aust, S., Spatzenegger, M., Thalhammer, T., Szekeres, T., et al. Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261 (3-18-2008), 172–182.
16. Yung, S., Li, F.K., Chan, T.M., Peritoneal mesothelial cell culture and biology. Perit Dial Int 26 (2006), 162–173.
17. Alkhamesi, N.A., Ziprin, P., Pfistermuller, K., Peck, D.H., Darzi, A.W., ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. Clin Exp Metastasis 22 (2005), 449–459.
18. Ahrens, T., Sleeman, J.P., Schempp, C.M., Howells, N., Hofmann, M., Ponta, H., et al. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid. Oncogene 20 (6-7-2001), 3399–3408.
19. Jones, L.M., Gardner, M.J., Catterall, J.B., Turner, G.A., Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis 13 (1995), 373–380.
20. Park, J.S., Kim, K.M., Kim, M.H., Chang, H.J., Baek, M.K., Kim, S.M., et al. Resveratrol inhibits tumor cell adhesion to endothelial cells by blocking ICAM-1 expression. Anticancer Res 29 (2009), 355–362.
21. Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., et al. Resveratrol inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Toxicology 303 (1-7-2013), 139–146.
22. Lee, H.S., Ha, A.W., Kim, W.K., Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract 6 (2012), 294–300.
23. Wu, H., Liang, X., Fang, Y., Qin, X., Zhang, Y., Liu, J., Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed Pharmacother 62 (2008), 613–621.
24. Cannistra, S.A., DeFranzo, B., Niloff, J., Ottensmeir, C., Functional heterogeneity of CD44 molecules in ovarian cancer cell lines. Clin Cancer Res 1 (1995), 333–342.
25. Ksiazek, K., Mikula-Pietrasik, J., Korybalska, K., Dworacki, G., Jorres, A., Witowski, J., Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin. Am J Pathol 174 (2009), 1230–1240.
26. Mikula-Pietrasik, J., Kuczmarska, A., Rubis, B., Filas, V., Murias, M., Zielinski, P., et al. Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms. Free Radic Biol Med 52 (6-1-2012), 2234–2245.
27. Le, C.L., Chalabi, N., Delort, L., Bignon, Y.J., Bernard-Gallon, D.J., Differential expression of genes induced by resveratrol in human breast cancer cell lines. Nutr Cancer 56 (2006), 193–203.
28. Wu, J., Guo, C., Liu, J., Xuan, X., Expression of integrin in hepatic fibrosis and intervention of resveratrol. Front Med China 3 (2009), 100–107.
29. Belleri, M., Ribatti, D., Savio, M., Stivala, L.A., Forti, L., Tanghetti, E., et al. alphavbeta3 integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Mol Cancer Ther 7 (2008), 3761–3770.
30. Lin, H.Y., Lansing, L., Merillon, J.M., Davis, F.B., Tang, H.Y., Shih, A., et al. Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J 20 (2006), 1742–1744.
31. Tamada, Y., Takeuchi, H., Suzuki, N., Aoki, D., Irimura, T., Cell surface expression of hyaluronan on human ovarian cancer cells inversely correlates with their adhesion to peritoneal mesothelial cells. Tumour Biol 33 (2012), 1215–1222.